Multinational, multi-database cohort study to assess adverse cardiovascular and cerebrovascular outcomes and mortality in association with inhaled NVA237 in Europe (NVA237 PASS)

25/10/2013
14/03/2024
EU PAS number:
EUPAS5035
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

NVA237A2402T-v03--protocol_Redacted

English (2.76 MB - PDF) View document
Study results
Study results

NVA237A2402T-Redacted-Final-Study-Report

English (6.63 MB - PDF) View document
Study report
Other information